--- title: "Vaxart (OTCMKTS:VXRT) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS" type: "News" locale: "en" url: "https://longbridge.com/en/news/295153294.md" description: "Vaxart reported quarterly earnings of ($0.06) EPS, beating analyst estimates of ($0.12). The company posted a net margin of 14.51% and return on equity of 61.43%. Shares traded down $0.02 to $0.57. Several institutions increased stakes, including Raymond James and Invesco. Zacks Research upgraded Vaxart to a 'hold' rating." datetime: "2026-08-06T22:41:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295153294.md) - [en](https://longbridge.com/en/news/295153294.md) - [zh-HK](https://longbridge.com/zh-HK/news/295153294.md) generator: "portal-rs" --- # Vaxart (OTCMKTS:VXRT) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS Vaxart (OTCMKTS:VXRT - Get Free Report) announced its earnings results on Thursday. The biotechnology company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.12) by $0.06, Zacks reports. Vaxart had a net margin of 14.51% and a return on equity of 61.43%. ## Vaxart Price Performance - 3 Stocks Under $5 With Strong Analyst Upside Potential Shares of OTCMKTS:VXRT traded down $0.02 on Thursday, hitting $0.57. 181,566 shares of the company's stock were exchanged, compared to its average volume of 557,097. The stock has a market capitalization of $138.42 million, a price-to-earnings ratio of 3.80 and a beta of 1.10. Vaxart has a 12 month low of $0.30 and a 12 month high of $0.84. The business's 50 day simple moving average is $0.56 and its two-hundred day simple moving average is $0.63. ## Institutional Inflows and Outflows Several institutional investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. increased its position in Vaxart by 16.9% during the 2nd quarter. Raymond James Financial Inc. now owns 236,166 shares of the biotechnology company's stock valued at $107,000 after purchasing an additional 34,075 shares during the period. Invesco Ltd. raised its holdings in shares of Vaxart by 93.1% in the 1st quarter. Invesco Ltd. now owns 146,366 shares of the biotechnology company's stock valued at $60,000 after purchasing an additional 70,568 shares in the last quarter. Creative Planning purchased a new stake in shares of Vaxart in the 2nd quarter worth approximately $33,000. Goldman Sachs Group Inc. purchased a new stake in shares of Vaxart in the 1st quarter worth approximately $31,000. Finally, Jones Financial Companies Lllp boosted its stake in shares of Vaxart by 276,364.7% during the first quarter. Jones Financial Companies Lllp now owns 478,284 shares of the biotechnology company's stock valued at $196,000 after purchasing an additional 478,111 shares in the last quarter. Hedge funds and other institutional investors own 18.05% of the company's stock. ## Wall Street Analyst Weigh In Separately, Zacks Research upgraded shares of Vaxart to a "hold" rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Vaxart currently has an average rating of "Hold". **Check Out Our Latest Stock Analysis on Vaxart** ## Vaxart Company Profile (Get Free Report) Vaxart, Inc is a clinical-stage biotechnology company pioneering the development of oral recombinant vaccines administered in tablet form. Leveraging a proprietary, room-temperature-stable platform, the company aims to simplify vaccine delivery while eliciting both systemic and mucosal immune responses. Its technology is based on the replication-defective adenovirus vector system, which encodes target antigens designed to protect against a range of infectious diseases without the need for injections or cold-chain logistics. The company’s pipeline includes multiple vaccine candidates in various stages of development. ## Further Reading - Five stocks we like better than Vaxart - Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is Falling - 4 Oil and Gas ETF Plays as Prices Stay Sky-High - What Tesla Stands to Lose If It Walks Away From China - Disney Sets Up for a Magical Year in 2027 *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* Continue following MarketBeat Add MarketBeat as your preferred source on Google to see our latest stories in your feed. Add As Preferred Source ## Should You Invest $1,000 in Vaxart Right Now? Before you consider Vaxart, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vaxart wasn't on the list. While Vaxart currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [VXRT.US](https://longbridge.com/en/quote/VXRT.US.md) - [IVZ.US](https://longbridge.com/en/quote/IVZ.US.md) - [RJF.US](https://longbridge.com/en/quote/RJF.US.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [SNDK.US](https://longbridge.com/en/quote/SNDK.US.md) - [TSLA.US](https://longbridge.com/en/quote/TSLA.US.md) - [DIS.US](https://longbridge.com/en/quote/DIS.US.md) - [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md) - [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md) ## Related News & Research - [U.S-based Invesco bullish on India debt, prefers long-term bonds, fund manager says](https://longbridge.com/en/news/296765745.md) - [Weekly Recap: 20% property fee cut and multi‑asset appointments](https://longbridge.com/en/news/296779819.md) - [Weber Capital Management LLC ADV Takes $2.35 Billion Position in Treace Medical Concepts, Inc. $TMCI](https://longbridge.com/en/news/296770854.md) - [Plato Investment Management Ltd Takes Position in Incyte Corporation $INCY](https://longbridge.com/en/news/296206161.md) - [1,307,234 Shares in Hormel Foods Corporation $HRL Bought by Deutsche Bank AG](https://longbridge.com/en/news/296676382.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**